Perspectives in Biology and Medicine 61 (2):201-214 (2018)

It's common knowledge that published medical findings tell only part of the story, the other part consisting of unpublished records of negative trials, sometimes of the same agents. No one, of course, knows precisely how much lies below the waterline, but informed estimates suggest that as many as half of all trials undertaken remain unreported —a percentage sufficient to cast a shadow over the entire corpus of published medical research. The effect is incalculable. That negative findings of trials of cancer chemotherapies would be withheld from publication seems inconceivable, but a paper documented that practice, and its slanting effect on the published literature, some 30 years ago....
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1353/pbm.2018.0037
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 59,864
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

No citations found.

Add more citations

Similar books and articles

Bias and Conditioning in Sequential Medical Trials.Cecilia Nardini & Jan Sprenger - 2013 - Philosophy of Science 80 (5):1053-1064.
Publication Bias: The Achilles' Heel of Systematic Reviews?Carole J. Torgerson - 2006 - British Journal of Educational Studies 54 (1):89 - 102.
Hollow Hunt for Harms.Jacob Stegenga - 2016 - Perspectives on Science 24 (5):481-504.


Added to PP index

Total views
3 ( #1,300,730 of 2,433,136 )

Recent downloads (6 months)
1 ( #463,753 of 2,433,136 )

How can I increase my downloads?


My notes